Patents by Inventor Anders Kronström

Anders Kronström has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Form of -omeprazole
    Patent number: 8466175
    Abstract: The present invention relates to a novel form of the (?)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: June 18, 2013
    Assignee: AstraZeneca AB
    Inventors: Hanna Cotton, Anders Kronström, Anders Mattson, Eva Möller
  • NOVEL FORM OF S-OMEPRAZOLE
    Publication number: 20120252847
    Abstract: The present invention relates to a novel form of the (?)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Application
    Filed: November 17, 2011
    Publication date: October 4, 2012
    Inventors: Hanna Cotton, Anders Kronström, Anders Mattson, Eva Mõller
  • Form of S-omeprazole
    Patent number: 8076361
    Abstract: The present invention relates to a novel form of the (?)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2 -pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: December 13, 2011
    Assignee: AstraZeneca AB
    Inventors: Hanna Cotton, Anders Kronström, Anders Mattson, Eva Möller
  • Novel Form of S-Omeprazole
    Publication number: 20110130570
    Abstract: The present invention relates to a novel form of the (?)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2 -pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Application
    Filed: May 21, 2010
    Publication date: June 2, 2011
    Inventors: Hanna Cotton, Anders Kronström, Anders Mattson, Eva Mõller
  • Form of -omeprazole
    Patent number: 7745466
    Abstract: The present invention relates to a novel form of the (?)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Grant
    Filed: September 11, 2007
    Date of Patent: June 29, 2010
    Assignee: AstraZeneca AB
    Inventors: Hanna Cotton, Anders Kronström, Anders Mattson, Eva Möller
  • Form of S-omeprazole
    Patent number: 7411070
    Abstract: The present invention relates to a novel form of the (?)-enantiomer of 5-methoxy-2[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: August 12, 2008
    Assignee: AstraZeneca AB
    Inventors: Hanna Cotton, Anders Kronström, Anders Mattson, Eva Möller
  • Process
    Patent number: 6747155
    Abstract: The present invention relates to a novel process for the preparation of the magnesium salt of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole trihydrate, i.e. S-omeprazole magnesium salt trihydrate. The present invention also relates to the S-omeprazole magnesium salt trihydrate prepared in accordance with the new process and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Grant
    Filed: April 1, 2002
    Date of Patent: June 8, 2004
    Assignee: AstraZeneca AB
    Inventors: Anders Kronström, Eva Leander, Anders Mattson, Karin Jansson, Martin Bohlin
  • Potassium salt of S-omeprazole
    Patent number: 6677455
    Abstract: The present invention relates to a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: January 13, 2004
    Assignee: AstraZeneca AB
    Inventors: Anders Kronström, Eva Leander, Anders Mattson
  • Form of S-omeprazole
    Patent number: 6369085
    Abstract: The present invention relates to a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: April 9, 2002
    Assignee: AstraZeneca AB
    Inventors: Hanna Cotton, Anders Kronström, Anders Mattson, Eva Möller